Related Experiment Video

Updated: May 9, 2026

A Modified Trier Social Stress Test for Vulnerable Mexican American Adolescents
06:15

A Modified Trier Social Stress Test for Vulnerable Mexican American Adolescents

Published on: July 10, 2017

Symptom occurrence and severity on the therapy-related symptom checklist for children among Hispanic pediatric

Phoebe D Williams1, Jane Robinson, Arthur R Williams

  • 1Author Affiliations: School of Nursing, University of Kansas, Kansas City (Dr P. Williams and Ms Robinson); School of Nursing, Washburn University, Topeka, Kansas (Ms Robinson); and Department of Health Policy & Management, College of Public Health, University of South Florida, Tampa (Dr A. Williams).

Cancer Nursing
|July 18, 2013
PubMed

Insights

The Therapy-Related Symptom Checklist for Children (TRSC-C) effectively monitors symptoms in Hispanic pediatric cancer patients. Its use is appropriate across various diagnoses and demographics in pediatric oncology treatment.

Area of Science:

  • Pediatric Oncology
  • Symptom Management
  • Health Disparities

Background:

  • The Therapy-Related Symptom Checklist for Children (TRSC-C) is a validated, user-friendly tool for monitoring cancer treatment symptoms in children.
  • Previous research established the TRSC-C's psychometric properties and effectiveness using "kid-friendly" language.
  • This study performs a secondary analysis focusing on a subsample of Hispanic pediatric oncology patients.

Purpose of the Study:

  • To evaluate symptom occurrence and severity using the TRSC-C in Hispanic pediatric oncology outpatients.
  • To examine the relationship between reported symptoms and patient demographics (gender, age).
  • To compare symptom scores between patients with acute lymphoblastic leukemia (ALL) and other cancer diagnoses.

Main Methods:

  • A cross-sectional analysis utilizing secondary data from 79 Hispanic pediatric oncology patients (ages 5-17).
  • The Therapy-Related Symptom Checklist for Children (TRSC-C) was administered via patient/parent report.
  • Descriptive statistics were employed to analyze symptom occurrence, severity, and group differences.

Main Results:

  • Fifteen symptoms were reported by 40% or more of the participants.
  • Eleven symptoms had a mean severity rating greater than "a little bit."
  • No significant differences in symptom scores were found based on gender or age; scores were similar between ALL and other diagnoses.

Conclusions:

  • Symptom occurrence and severity findings in this Hispanic subsample align with previous TRSC-C calibration studies and other ethnic groups.
  • The TRSC-C is confirmed as an appropriate tool for assessing symptoms in Hispanic pediatric oncology patients.
  • The checklist's utility extends to diverse pediatric oncology populations, supporting its use in clinical practice.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...